Artiva Biotherapeutics Inc (NAS:ARTV)
$ 11.24 -0.27 (-2.3%) Market Cap: 549.77 Mil Enterprise Value: 210.22 Mil PE Ratio: 0 PB Ratio: 1.28 GF Score: 12/100

Artiva Biotherapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 4, 2026 / 06:10 PM GMT
Release Date Price: $5.46 (-0.18%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ARTV.OQ - Artiva Biotherapeutics Inc
Artiva Biotherapeutics Inc at TD Cowen Healthcare Conference
Mar 04, 2026 / 06:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon everyone. Tyler Van Buren here, senior biotech analyst at TD Cowan.

Thank you very much for joining TD Cowan's forty-sixth annual healthcare conference. For our next session, excited to have a hybrid presentation and fireside chat with Artiva, and it's my pleasure to introduce Doctor Fred Aslan, the President and CEO of Artiva. Fred, privilege to have you here.

Thank you for joining me. I'll go ahead and hand it over to you for the presentation.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thanks Tyler and thanks for
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot